Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue $ 0 $ 0
Operating Expenses    
General and administrative 1,782,860 1,936,755
Research and development 369,450 389,824
Total Operating Expenses 2,152,310 2,326,579
Other Operating Income    
Grant income 103,319 0
Total Other Operating Income 103,319 0
Total Operating Loss (2,048,991) (2,326,579)
Other Income    
Interest income 3,309 62,493
Foreign Transaction gain 33,694 0
Total Other Income 37,003 62,493
Net Loss Before Income Taxes (2,011,988) (2,264,086)
Income Taxes 0 0
Net Loss (2,011,988) (2,264,086)
Accumulated Preferred Stock Dividend (131,434) (125,911)
Deemed additional dividend on preferred stock dividend due to the beneficial conversion feature (57,489) (54,317)
Net Loss Attributable to Common Shareholders $ (2,200,911) $ (2,444,314)
Net Loss Per Common Share    
Basic and Diluted $ (0.33) $ (0.74)
Weighted Average Number of Common Shares Outstanding 6,589,392 3,294,998